Concourse Financial Group Securities, Inc. Greenwich Life Sciences, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding GLSI
# of Institutions
35Shares Held
1.01MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$4.45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA268KShares$3.86 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA128KShares$1.84 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.25 Million0.01% of portfolio
-
State Street Corp Boston, MA68.4KShares$984,3190.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $185M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...